tin difluoride
Small moleculeexperimental
Clinical trial activity
36 trials · 14 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
11
Phase 3
10
Phase 4
6
Earliest trial started May 1, 2008 (NCT00762177)
Timeline
Indications
Approved for
Mechanism of action
- Mucin-1BINDING AGENT
MUC1 binding agent
Chemistry & pharmacology
- Mol. weight
- 156.71 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1909079 ↗
Also known as
- difluorostannylene
- difluorostannylene
- difluorostannylene
- fluoristan
- fluoristan
- fluoristan
- omnigel
- stannous fluoride
- stannous fluoride
- stannous fluoride
- stannous fluoride
- stannous fluoride
- stannous fluoride
- stannous fluoride
- stannous fluoride
- stop
- stop
- tin difluoride
- tin difluoride
- tin difluoride
- tin(ii) fluoride
- tin(ii) fluoride
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07215767 | Phase 3 | Sep 16, 2025 | All Sum Research Center Ltd., Healeon Medical Inc, Salus Research |
| NCT06660069 | N/A | Nov 18, 2024 | Healeon Medical Inc |
| NCT06045026 | N/A | Sep 21, 2023 | Healeon Medical Inc |
| NCT06197555 | N/A | May 1, 2022 | Altinbas University |
| NCT05326373 | N/A | Apr 11, 2022 | Procter and Gamble |
| NCT05483062 | N/A | May 20, 2021 | Minia University |
| NCT03943095 | Phase 2 | May 13, 2019 | GlaxoSmithKline |
| NCT02937636 | N/A | Sep 19, 2017 | GlaxoSmithKline |
| NCT03296657 | N/A | Aug 23, 2017 | Procter and Gamble, Salus Research |
| NCT02924350 | N/A | Nov 7, 2016 | GlaxoSmithKline |
| NCT02923895 | Phase 4 | Oct 11, 2016 | GlaxoSmithKline |
| NCT02841839 | N/A | Jun 1, 2016 | Procter and Gamble |
| NCT02752958 | N/A | May 1, 2016 | GlaxoSmithKline |
| NCT02731833 | Phase 4 | Apr 1, 2016 | GlaxoSmithKline |
| NCT02832375 | Phase 3 | Mar 1, 2016 | GlaxoSmithKline |
| NCT02750943 | N/A | Nov 1, 2015 | GlaxoSmithKline |
| NCT02613117 | N/A | Nov 1, 2015 | Procter and Gamble |
| NCT02613130 | N/A | Nov 1, 2015 | Procter and Gamble |
| NCT02574221 | N/A | Aug 1, 2015 | Procter and Gamble |
| NCT02513212 | N/A | Jul 1, 2015 | Procter and Gamble |
Showing 20 of 36 trials
Page 1 / 2
Organizations
Research & Development (14)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 16 | 16 | 4 | 2009 |
| Procter and Gamble | For profit | 10 | 10 | 1 | 2012 |
| Colgate Palmolive | For profit | 4 | 4 | 2 | 2008 |
| Healeon Medical Inc | For profit | 3 | 3 | 2 | 2023 |
| Salus Research | For profit | 2 | 0 | 2 | 2017 |
| All Sum Research Center Ltd. | For profit | 1 | 0 | 1 | 2025 |
| Altinbas University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Chad J Anderson DMD Inc | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Gaba International AG | For profit | 1 | 0 | 1 | 2010 |
| Loma Linda University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Minia University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Technical University of Dresden | Academic/Hospital | 1 | 1 | 1 | 2010 |
| University of Alabama | Academic/Hospital | 1 | 0 | 1 | 2012 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2012 |
14 organizations
Page 1 / 1